Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples